Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.“Every month that that drug is delayed means that I have to get chemo two more times,” said Dr. Ronald Silvestri, 77, a retired pulmonologist who has metastatic pancreatic cancer.
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Scritto il 01/05/2026